While stocks have enjoyed a strong start to 2024, CNBC Pro found that there are still plenty of opportunities for investors seeking companies offering growth potential for cheap. The S & P 500 jumped 10.2% in the first quarter, while the Dow Jones Industrial Average and Nasdaq Composite gained 5.6% and 9.1%, respectively. The first two days of the second quarter are off to a rockier start. The three major averages are all down more than 1%. So far, only the energy sector is positive for the month. The technology sector, which propelled the market's gains since October 2023, is down about 1.2% in April. With this in mind, CNBC Pro screened for stocks that can give investors “growth at a reasonable price,” or GARP. That is a popular investment methodology focusing on stocks with both strong growth prospects and attractive valuations, combining both offensive and defensive characteristics in a portfolio. The screener showed that GARP opportunities exist in a diverse array of sectors across the S & P 500. The names met all of the following criteria: Earnings per share growth over 10% Sales growth over 10% Trading at a discount relative to their S & P 500 sector on a next 12-month basis Several consumer discretionary names made the GARP list. Cruise line Royal Caribbean and casino company Las Vegas Sands could both grow their earnings by more than 40% this fiscal year. Royal Caribbean is currently trading at a price-to-forward-earnings ratio of 13.2, while Las Vegas Sands has a forward P/E of 18.4. RCL LVS,.SPX YTD mountain Royal Caribbean and Las Vegas Sands versus the S & P 500 in 2024 Restaurant chain Yum Brands also turned up. The stock is lagging the S & P 500 in 2024, rising 6.8% compared to the broader market's 8.8% increase. But the Taco Bell parent is estimated by analysts to see earnings per share grow 12% in 2024. Health-care names Cigna Group and Cardinal Health are other GARP opportunities for investors. Cigna is trading at a 12.2 forward P/E ratio, with earnings estimated to jump 13.3%. The stock has already rallied nearly 21% year to date. Cardinal Health's earnings could surge 26%. The stock is trading at a slightly higher forward P/E ratio than Cigna, at 14.3. Shares are up 9.9% in 2024.
News Related-
Leon Cooperman says it's a stock picker's market. Here are his new favorite bets
Billionaire investor Leon Cooperman thinks that it's a stock picker's market and only individual names will offer value for investors as the overall market struggles. A new filing just revealed his top selections. The chair and CEO of Omega Advisors held about $167 million worth of Energy Transfer at the ...
See Details: Leon Cooperman says it's a stock picker's market. Here are his new favorite bets -
These bond funds are among the top performers in 2023 – Here’s what investors should do next
It's been a good year for yield-chasing investors willing to take some risk in fixed income. The Federal Reserve's rate hikes since March 2022 have had the pleasant side effect of lifting yields on interest-bearing assets ranging from Treasury bills to money market funds. The lowly 1-year certificate of deposit ...
See Details: These bond funds are among the top performers in 2023 – Here’s what investors should do next -
Goldman's hedge fund VIP portfolio is up 31% this year. These are the stocks on the list
Hedge funds' favorite stocks have crushed the broader market in 2023, returning 31%, thanks to mega-cap technology companies, according to Goldman Sachs. The Wall Street bank analyzed the holdings of 735 hedge funds with $2.4 trillion of both long and short equity positions at the start of the fourth quarter, ...
See Details: Goldman's hedge fund VIP portfolio is up 31% this year. These are the stocks on the list -
A bearish options bet against this coffee stock showing some fatigue
Identifying underperforming stocks is becoming a challenge, with the broader market approaching new highs. Starbucks (SBUX) looks like it could be an interesting stock to bet against. While the stock saw an impressive 18% surge post an earnings beat at the start of the month, it's displaying indications of fatigue, ...
See Details: A bearish options bet against this coffee stock showing some fatigue